I'm bullish on Vertex (VRTX)
buying 100 shares at 25.25
Their lead drug candidate looks pretty promising. New data came out that seems fantastic at least on the surface.
It did have a run-up about a month ago, based on some positive results with this drug and their cystic fibrosis program, but it is still well off its all-time high of around 40. Still think it has a while to run. Plan to hold at least 2 years
Quote:
|
Vertex Pharmaceuticals Incorporated (Vertex) is a biotechnology company in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Telaprevir, lead drug candidate, is an oral hepatitis C protease inhibitor and one of the advanced of a new class of antiviral treatments in clinical development that target hepatitis C virus (HCV), infection. Vertex’s other drug candidates are VX-770 and VX-809, two drug candidates targeting cystic fibrosis, or CF; VX-500 and VX-813, two second-generation HCV protease inhibitors; and VX-509, a janus kinase 3, or JAK3, inhibitor that targets immune-mediated inflammatory diseases, or IMID. The Company also includes several drug candidates that are being developed by its collaborators.
|